focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion Venture Regulatory News (AAVC)

Share Price Information for Albion Venture (AAVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 42.20
Ask: 44.20
Change: 0.00 (0.00%)
Spread: 2.00 (4.739%)
Open: 43.20
High: 43.20
Low: 43.20
Prev. Close: 43.20
AAVC Live PriceLast checked at -
Albion VCT is an Investment Trust

To manage risk normally associated with investments in smaller, unquoted growth businesses across a variety of sectors including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Venture Capital Trust PLC: Interim Management Statement

6 Sep 2022 12:00

Albion Venture Capital Trust PLC: Interim Management Statement

ALBION VENTURE CAPITAL TRUST PLCLEI Code: 213800JKELS32V2OK421Interim Management Statement

IntroductionI present Albion Venture Capital Trust PLC (the “Company”)’s interim management statement for the period from 1 April 2022 to 30 June 2022.

Performance and dividendsThe Company's unaudited net asset value (NAV) as at 30 June 2022 was £65.3 million or 53.79 pence per share (excluding treasury shares), an increase of 0.41 pence per share (0.8 per cent.) since 31 March 2022.

After accounting for the first dividend for the year ending 31 March 2023 of 1.33 pence per share paid on 29 July 2022 to shareholders on the register on 8 July 2022, the NAV is 52.46 pence per share.

Fundraising and share issuesDuring the period from 1 April 2022 to 30 June 2022, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2021/22:

DateNumber of shares issuedIssue price per share (including costs of issue)Net proceeds £'000
11 April 20221,596,75152.3p to 52.8p822

PortfolioThe following investments have been made during the period from 1 April 2022 to 30 June 2022.

New investments£000’sActivity
PeakData564Provides insights and analytics to pharmaceutical companies about therapeutic areas.
Ophelos433An autonomous debt resolution platform.
Total new investments997 

Further investments£000’sActivity
Gravitee TopCo (T/A Gravitee.io)711An API management platform.
Cantab Research (T/A Speechmatics)436Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across over 31 languages.
Accelex Technology308Data extraction and analytics technology for private capital markets.
Concirrus97A software provider bringing real-time behavioural data analytics to the marine and transport insurance industries.
Total further investments1,552 

Top ten holdings as at 30 June 2022

InvestmentCarrying value£000’s% of net asset valueActivity
Chonais River Hydro4,4116.8%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands.
Cantab Research (T/A Speechmatics)3,5585.4%Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across over 31 languages.
Elliptic Enterprises2,6264.0%Provider of Anti Money Laundering services to digital asset institutions.
Radnor House School (TopCo)2,4763.8%Independent school for children aged 2-18.
The Evewell Group2,4253.7%Operator and developer of women’s health centres focusing on fertility.
Seldon Technologies2,2123.4%Software company that enables enterprises to deploy Machine Learning models in production.
Gravitee TopCo (T/A Gravitee.io)1,9152.9%An API management platform.
Gharagain River Hydro1,8952.9%Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands.
NuvoAir Holdings1,3892.1%Digital therapeutics and decentralised clinical trials for respiratory conditions.
TransFICC1,2962.0%A provider of a connectivity solution, connecting financial institutions with trading venues via a single API.

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC.

Share buy-backsDuring the period from 1 April 2022 to 30 June 2022, the Company did not buy back any shares.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

Shareholder seminarThe Board is pleased to report that the Manager, Albion Capital, is to host a physical shareholder seminar this year on 23 November 2022, at the Royal College of Surgeons, Lincoln’s Inn Field, London. The Board and Manager are keen to interact with shareholders and look forward to sharing with you further portfolio updates, as well as answering any questions.

To reserve a place, email info@albion.capital.

Material events and transactions after the period endOther than as described above, there have been no material events or transactions during the quarter and to the date of this announcement.

Further informationThe Company continues to offer a dividend reinvestment scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/AAVC.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC.

Richard Glover, Chairman6 September 2022

For further information please contact:

Vikash HansraniOperations PartnerAlbion Capital Group LLPTelephone: 020 7601 1850

Date   Source Headline
29th Jun 20074:54 pmRNSFinal Results
29th Jun 20074:21 pmRNSCircular to Shareholders
1st Jun 200710:30 amRNSTotal Voting Rights
1st May 20073:02 pmRNSVoting Rights and Capital
2nd Apr 20079:22 amRNSVoting Rights and Capital
20th Mar 20073:31 pmRNSChange in dividend allocation
20th Mar 20073:30 pmRNSNet Asset Value(s)
12th Mar 200711:30 amRNSDoc re letter to shareholders
5th Mar 20077:30 amRNSDividend Declaration
1st Mar 20073:10 pmRNSVoting rights and capital
1st Feb 20073:59 pmRNSVoting rights and capital
12th Jan 20079:51 amRNSDocument viewing
22nd Dec 200610:50 amRNSVoting Rights & Capital
7th Dec 20064:05 pmRNSInterim Results
18th Aug 20062:04 pmRNSNet Asset Value(s)
31st Jul 200610:38 amRNSAnnual Information Update
18th Jul 200610:15 amRNSDoc re. Rep.&Fin. statements
21st Jun 20062:26 pmRNSHolding(s) in Company
28th Feb 200612:00 pmRNSDividend Declaration
31st Jan 20062:43 pmRNSNet Asset Value(s)
13th Jan 20061:00 pmRNSDoc re. interim results
14th Dec 20054:33 pmRNSInterim Results
10th Jun 200511:51 amRNSDirector Shareholding
9th Jun 20054:07 pmRNSFinal Results
24th Jan 20054:56 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.